Previous studies indicated that histone hyperacetylation resulting from HDAC repression leads to neuroprotection.42 HDAC inhibition may be a therapeutic approach for NP management.11,38 Panobinostat is mainly used to treat multiple myeloma. This evidence concerns the gene HDAC9 and plasma cell myeloma.